(Total Views: 263)
Posted On: 02/08/2019 4:38:32 PM
Post# of 72436
![Avatar](https://investorshangout.com/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
This seems to verify that they are going for approval under the easier European standards first.
As I've said before, it's possible that Bril-OM might be considered a "medical device" under European guidelines, as it is not ingested but is a "topical" treatment for the oral membranes. Medical devices are a lot easier to get approved.
Quote:
Subsequent to the balance sheet date, the Company is establishing a wholly-owned European subsidiary for the purpose of the development of its drug candidates internationally. The subsidiary will serve as a key hub for strategic collaboration with European companies and medical communities in addition to providing cost-saving efficiencies and flexibility with respect to developing Brilacidin under European Medicines Agency standards.
As I've said before, it's possible that Bril-OM might be considered a "medical device" under European guidelines, as it is not ingested but is a "topical" treatment for the oral membranes. Medical devices are a lot easier to get approved.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)